The full report is titled “Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus. A Randomized Trial.” The authors are K. Cusi, B. Orsak, F. Bril, R. Lomonaco, J. Hecht, C. Ortiz-Lopez, F. Tio, J. Hardies, C. Darland, N. Musi, A. Webb, and P. Portillo-Sanchez.
Pioglitazone for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes. Ann Intern Med. 2016;165:I–15. [Epub ahead of print 21 June 2016]. doi: https://doi.org/10.7326/P16-9018
Download citation file:
Published: Ann Intern Med. 2016;165(5):I-15.
Published at www.annals.org on 21 June 2016
Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism, Gastroenterology/Hepatology.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use